SPAZO2 (SOGUG): Comparative effectiveness of pazopanib in metastatic renal carcinoma (mRC): Ineligible (I) vs eligible (E) patients for clinical trials
Arranz Arija, J., Pérez Valderrama, B., Rodríguez Sánchez, Á., Chirivella González, I., Anido Herranz, U., Maroto Rey, J.P., Miranda Pallares, M.J., Climent Duran, M.A., Crespo Herrero, G., Meana Garcia, J.A., Rodriguez-Vida, A., Fernandez-Rodriguez, R., Santander, C., Rubio Romero, G., Vazquez Estevez, S., Fernandez Calvo, O., Gonzalez Gragera, M.B., Almagro Casado, E., Perez Ramirez, S., Borrega García, P.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article